Breakthrough! Targeting the intracellular bacterial community of tumors to achieve over 700 days of no recurrence in cancer treatment. Combining antibacterial and anti-tumor therapies opens up a new p

已传文件：photo/1773121782.png Recently, a significant study was published in Nature Communications. The research team for the first time combined the antibacterial strategy targeting the tumor-resident intracellular microbiota (TRIM) with multi-modal anti-tumor therapies. They achieve